Advertisement

Topics

Astellas pays $102.5mm for Universal Cells

14:40 EST 14 Feb 2018 | Elsevier Business Intelligence

Astellas Pharma Inc. is paying $102.5mm to acquire private stem cell therapeutics developer Universal Cells Inc. The agreemen...

Original Article: Astellas pays $102.5mm for Universal Cells

NEXT ARTICLE

More From BioPortfolio on "Astellas pays $102.5mm for Universal Cells"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...